Stock

Honda recalls 750,000 U.S. vehicles over air bag defect

Honda said on Tuesday it was recalling 750,000 vehicles in the United States over a defect involving air bags which could deploy unintentionally during a crash.

The front passenger seat weight sensor may crack and short circuit, failing to suppress the air bag as intended, the National Highway Traffic Safety Administration (NHTSA) said on Tuesday. Dealers will replace the seat weight sensors.

The recall includes certain Honda Pilot, Accord and Civic vehicles from the 2020-2022 model years, and some Honda CR-V and Passport vehicles from the 2020 and 2021 model years.

Honda, in a statement filed with the safety regulator, said it had 3,834 warranty claims, and that there were no reports of injuries or deaths related to the recall issue since June 2020.

In a bid to explain how the defect may have originated, Honda told the NHTSA that after a natural disaster impacted the manufacturing plant of a subcontractor, a supplier temporarily changed the base material in the printed circuit board of the seat weight sensor. The alternative material used “could allow additional strain to the printed circuit board”, it said.

Toyota in December recalled 1.12 million vehicles worldwide because a short circuit in a sensor could cause air bags not to deploy as designed.

Also in December, Honda recalled 4.5 million vehicles worldwide over risks of fuel pump failure, which included 2.54 million vehicles in the United States.

This post appeared first on NBC NEWS

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version